Research LettersNew BRCA2 mutation in an Ashkenazi Jewish family with breast and ovarian cancer
References (5)
- et al.
BRCA1 mutations in Ashkenazi Jewish women
Am J Hum Genet
(1995) - et al.
Germline BRCA1 185delAG mutations in Jewish women with breast cancer
Lancet
(1996)
There are more references available in the full text version of this article.
Cited by (15)
Genetic tests to identify risk for breast cancer
2015, Seminars in Oncology NursingCitation Excerpt :The National Comprehensive Cancer Network (NCCN) 2014 guidelines on genetic/familial high-risk assessment in breast and ovarian cancer outline the criteria for multi-gene testing in breast cancer, specifically pointing to the clinical relevance of the TP53, PTEN, ATM, and PALB2 genes, in addition to BRCA1 and BRCA2.9 Genetic tests currently on the market are detailed in Table 12,6,10-28 with their corresponding trade names. These tests screen for known point mutations, small deletions, and large chromosomal rearrangements.
Hereditary breast cancer
2001, Current Problems in SurgeryLaboratory identification of hereditary risk of breast and ovarian cancer
1999, Current Opinion in BiotechnologyObtaining and using genetic information
2011, Inherited Cancer Syndromes: Current Clinical ManagementBRCA germline mutations in Jewish patients with pancreatic adenocarcinoma
2009, Journal of Clinical Oncology
Copyright © 1997 Elsevier Ltd. All rights reserved.